H. Clarke et al., Regulation of protein kinase C-delta and -epsilon isoforms by phorbol ester treatment of LLC-PK1 renal epithelia, KIDNEY INT, 58(3), 2000, pp. 1004-1015
Background. LLC-PK1 renal epithelia are a widely used model for proximal tu
bular physiology and differentiation. Protein kinase C (PKC) has been obser
ved to play a role in both processes. This study examines the subcellular d
istribution and down-regulation of PKC-delta and PKC-epsilon isoforms in ph
orbol eater-treated LLC-PK1 epithelia.
Methods. Cells were treated with 10(-7) mol/L 12-O-tetradecanoyl phorbol 13
-acetate (TPA) for up to seven days and were extracted as total cell lysate
s as well as cytosolic, membrane-associated (Triton-X soluble) and a third
(Triton-X insoluble) fraction. The expression and cellular localization of
PKC-delta and PKC-epsilon isoforms were then detected using Western immunob
lot and immunofluorescence.
Results. Based on the use of an anti-PKC-delta monoclonal antibody, TPA was
observed to cause a rapid decrease in total PKC-delta content, which then
returned to near control levels by seven days of treatment. Immunofluoresce
nce indicated that PKC-delta had a cytoskeletal localization within the cel
ls, and a subtle cytoskeletal rearrangement occurred upon exposure to TPA.
Western immunoblots showed that PKC-delta did not undergo the expected memb
rane translocation upon activation by TPA, but simply disappeared immediate
ly from the cytosolic compartment. Conventional cell fractionation procedur
es such as homogenization and Triton extraction prior to Western immunoblot
will, however, fail to evaluate completely PKC-delta in LLC-PK1 epithelia
because of the highly stringent measures necessary to extract PKC-delta fro
m the cytoskeletal compartment of these cells. Furthermore, we observed tha
t a second (polyclonal) PKC-delta antibody may recognize phosphorylated for
ms of PKC-delta, which went unrecognized by the other antibody. PKC-epsilon
was present in the cytosol, membrane, and Triton-X-insoluble fractions of
the cells. TPA treatment resulted in a partial translocation of PKC-epsilon
to both the membrane and Triton-X-insoluble fractions of the cell, but tot
al PKC-epsilon remained essentially unchanged.
Conclusions. The present data indicate that the localization of PKC-delta a
nd subsequent redistribution within the LLC-PK1 cells in response to TPA tr
eatment is highly unique and distinct from that of PKC-E and PKC-ol. An imp
ortant methodological finding is that one given antibody may not recognize
all phosphoproteins of a given PKC isoform.